Final Conference Program - aatod

More documents

Recommendations

Info

Conference Sessions Tuesday, October 26, 2010 Tuesday Continental Breakfast 7:30 a.m.–8:30 a.m., Southwest Hall Sponsored by Reckitt Benckiser Pharmaceuticals, Inc. MIDDLE PLENARY SESSION 8:45 a.m.–10:15 a.m. Addiction, Pharmacology and the Criminal Justice System: What are the Challenges to Expanding the Use of Pharmacologic Treatment Interventions for Opioid Dependent Individuals Under the Jurisdiction of the Criminal Justice System International North Moderator Speakers Melody Heaps, President Emeritus, Treatment Alternatives for Safer Communities, Chicago, IL West Huddleston, President, National Association of Drug Court Professionals, Alexandria, VA Scott Chavez, Vice President, National Commission on Correctional Healthcare, Chicago, IL Dawn Bushma, LCSW, Senior US Probation Officer, US Probation Office, Chicago, IL This plenary will be moderated by Melody Heaps, President Emeritus, Treatment Alternatives for Safer Communities. Despite the fact that science has confirmed that addiction is a brain disease and not a question of lack of will power or moral failure, certain public sectors have been resistant to using medication-assisted treatment. In particular, the criminal justice system has resisted, and in some cases prohibited the use of such treatment for addicted individuals. This plenary will explore the reasons behind such resistance, discuss models of pharmacological treatments within the justice system, the challenges treatment systems face in working with the criminal justice system, and the future of medication-assisted treatment in the criminal justice system. 10:30 a.m.–12:00 p.m. WORKSHOP SESSIONS C1 Alcohol Abuse in Methadone Treatment: Understanding and Addressing a Serious Problem International South Allan J. Cohen, MA, Bay Area Addiction, Research and Treatment, Inc. (BAART), Los Angeles, CA Daniel D. George, MPH, Matrix Institute on Addictions, Los Angeles, CA Alcohol abuse in methadone maintained patients has proven to be among the most costly and difficult problems to successfully address and treat in the opioid treatment program. The costs of this problem in terms of patient mortality, poor treatment outcomes, staff and program resources and negative community impact are enormous. This workshop will present an overview of the problem of alcohol abuse in methadone maintained patient populations including a review of past and current research on this issue. We will explore an array of clinical and programmatic issues related to alcohol abuse and discuss treatment options. * Note: Basic Track AMA PRA Category 1 Credit approved. C2 An Analysis of Opioid-Addicted Medicaid Patients in Baltimore City Continental A Gregory C. Warren, MA, Baltimore Substance Abuse Systems, Inc., Baltimore, MD Utilizing a coordinated public health response, Buprenorphine medication and innovative clinical and financial processes have been created to improve access and treatment outcomes for heroin addicts in Baltimore. There will be three areas of discussion in the workshop. First, critical lessons learned in how to establish a buprenorphine induction and stabilization continuum of care will be discussed. Organizational change and new interagency partnerships needed to be forged to address the cultural, regulatory and financial barriers which needed to be overcome. Finally, the presenter will share Baltimore’s outcomes and preliminary research findings and whether these changes achieved savings in health care utilization. C3 The Georgia Strategy for Stigma Reduction Continental B Jonathan Connell, MA, Private Clinic, Albany, GA Stacey Pearce, BS, GPA Treatment of Macon, Inc., Macon, GA Joelyn Alfred, MS, Opioid Treatment Providers of Georgia, Norcross, GA For years, treatment providers quietly provided treatment without confronting the stigma in our communities. This presentation is designed to demonstrate the process Opioid Treatment Providers of Georgia went through to confront the stigma within the state of Georgia associated with Medication Assisted Treatment. Presenters 16 AATOD National Conference | Building Partnerships: Advancing Treatment & Recovery
will discuss the collaborative process undertaken in developing the video “Exploring the World of Opioid Dependence” and how it is presently being utilized in education and stigma reduction efforts. In addition, information will be provided on how to develop a comprehensive plan for stigma reduction including planning for a Methadone Treatment Awareness Day. C4 Improving Access and Retention in Treatment International North Kimberly Johnson, MBA, University of Wisconsin, Madison, WI This workshop will share results of a year-long project that involved 30 agencies working together to improve access to and retention in treatment using the NIATx model of process improvement. By making simple changes like decreasing paperwork, reorganizing group times, staffing for intake and accelerating dosing, these 30 agencies reduced wait times, reduced no shows, improved group attendance and increased retention. We will share how they did it and discuss opportunities for programs that may be interested in participating in a future learning collaborative. C5 Partnering with Patients: Developing an Effective Peer Mentoring Program Continental C Robert C. Lambert, MA, Program Director, Connecticut Counseling Centers, Inc., Norwalk, CT Kurt Kemmling, CMA, Director/Founder, CT Chapter National Alliance Medication Assisted Recovery (NAMA), Danbury, CT This workshop will focus on the development, implementation and integration of peer mentoring services within a methadone treatment program, with a specific focus on strengthening the therapeutic alliance between the patient and the program. Potential benefits relating to patient outcomes and staff utilization management will be discussed. The presenters will focus on providing information the workshop participants will need to replicate all or part of the initiative at their own programs. One key area of focus will be the development and implementation of a training curriculum for the peer mentors including a specific focus on co-occurring disorders. 1:30 p.m.–3:00 p.m. WORKSHOP SESSIONS D1 Overdose Prevention and Treatment in Opioid Treatment Programs International North Alexander Walley, MD, Boston University School of Medicine, Boston, MA Melinda M. Campopiano, MD, UPMC Mercy Family Medicine Residency Program, Pittsburgh, PA Maya Doe-Simkins, MPH, Boston Medical Center, Boston, MA Overdose is a significant public health concern. Unintentional poisoning was second only to motor vehicle injuries as causes of unintentional injury deaths in 2006. A CDC report showed that opioid analgesics were involved in almost 40% of all poisoning deaths in 2006. Recent data from opioid treatment programs (OTPs) suggest that overdose is an important factor in mortality of patients in treatment. Evidence suggests that overdose prevention programs are feasible and effective. OTPs are in an important position to implement overdose prevention programs. This workshop is designed to improve knowledge about opioid overdose, including risk factors, prevention, identification and management. *Note: Basic Track Sponsored by the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment (SAMHSA/CSAT). AMA PRA Category 1 Credit approved. D2 Buprenorphine Pilot Project with Parolees in IL Continental A Dona Howell, CRADC, Illinois Department of Corrections, Marion, IL Janelle Prueter, CRADC, TASC, Chicago, IL Arturo Valdez, CSADC, Heritage Alternative Systems, Chicago, IL Illinois’ Sheridan Correctional Center Project has gained national attention for its comprehensive approach to reducing recidivism among drug-involved offenders. Sheridan parolees were 15% less likely to be rearrested for a new crime and 40% less likely to return to prison for a new crime or technical violation. Success rates for parolees with a history of opiate dependence have lagged behind those for the population as a whole. To address this disparity in outcomes, the Illinois Department of Corrections and its partners are implementing a pilot project that will integrate medication-assisted treatment into the continuum of care for parolees. D3 National Drug and Alcohol Policy: 2010 and Beyond International South Paul Samuels, JD, Legal Action Center, New York, NY Gabrielle de la Gueronniere, JD, Legal Action Center, Washington, DC Dan Belnap, JD, Legal Action Center, Washington, DC Now is a time of tremendous opportunity for improving the federal response to drug and alcohol addiction. The federal healthcare reform law has strong coverage for addiction treatment. New pro - grams and proposals at key federal agencies have the potential to significantly impact the treatment delivery system, and increased coverage for critical drug and alcohol-related services means more people in need of treatment will be able to access it. This workshop will discuss these federal developments for addiction treatment, what it means for medication-assisted treatment specifically, and the opportunities available for improving federal policy moving forward. October 23–27, 2010 | Hilton Chicago, Chicago, Illinois 17
Page 1 and 2: NATIONAL CONFERENCE Building Partne
Page 3 and 4: LETTER FROM THE CONFERENCE CHAIR De
Page 5 and 6: Pre-Conference Sessions Saturday, O
Page 7 and 8: MODULE DESCRIPTIONS Module One: Int
Page 9 and 10: The session also provides nurses wi
Page 11 and 12: disorders, medical care and vocatio
Page 13 and 14: Southwest Hall 16 Sex and Drug Usin
Page 15 and 16: presented will include neonatal and
Page 17: This workshop will preview and disc
Page 21 and 22: with serum levels, and collaborativ
Page 23 and 24: Conference Sessions Wednesday, Octo
Page 25 and 26: F5 Using Patient Chart Audits to Im
Page 27 and 28: ecap and a valuable training tool t
Page 29 and 30: Sweet Home Chicago “C’mon, Oh b
Page 31 and 32: Alkermes, Inc. is a fully integrate
Page 33 and 34: medical, social, and public health
Page 35 and 36: Continuing Education SAMHSA is a pu

Final Conference Program - aatod

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?